Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in Alzheimers Dement

Retrieve available abstracts of 250 articles:
HTML format
Text format



Single Articles


    June 2018
  1. RUTHIRAKUHAN M, Lanctot KL, Di Scipio M, Ahmed M, et al
    Biomarkers of agitation and aggression in Alzheimer's disease: A systematic review.
    Alzheimers Dement. 2018 Jun 22. pii: S1552-5260(18)30157.
    PubMed     Text format     Abstract available


  2. HANSSON O, Mikulskis A, Fagan AM, Teunissen C, et al
    The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review.
    Alzheimers Dement. 2018 Jun 22. pii: S1552-5260(18)30162.
    PubMed     Text format     Abstract available


  3. YOO HS, Jeon S, Chung SJ, Evans AC, et al
    Olfactory dysfunction in Alzheimer's disease- and Lewy body-related cognitive impairment.
    Alzheimers Dement. 2018 Jun 21. pii: S1552-5260(18)30164.
    PubMed     Text format     Abstract available


  4. CUMMINGS J
    The National Institute on Aging-Alzheimer's Association Framework on Alzheimer's disease: Application to clinical trials.
    Alzheimers Dement. 2018 Jun 21. pii: S1552-5260(18)30160.
    PubMed     Text format     Abstract available


    May 2018
  5. NEBEL RA, Aggarwal NT, Barnes LL, Gallagher A, et al
    Understanding the impact of sex and gender in Alzheimer's disease: A call to action.
    Alzheimers Dement. 2018 May 31. pii: S1552-5260(18)30130.
    PubMed     Text format     Abstract available


  6. KHACHATURIAN AS, Hayden KM, Mielke MM, Tang Y, et al
    New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia.
    Alzheimers Dement. 2018 May 26. pii: S1552-5260(18)30155.
    PubMed     Text format    


  7. BUCKLEY RF, Mormino EC, Amariglio RE, Properzi MJ, et al
    Sex, amyloid, and APOE epsilon4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts.
    Alzheimers Dement. 2018 May 24. pii: S1552-5260(18)30132.
    PubMed     Text format     Abstract available


  8. TEIPEL SJ, Cavedo E, Lista S, Habert MO, et al
    Effect of Alzheimer's disease risk and protective factors on cognitive trajectories in subjective memory complainers.
    Alzheimers Dement. 2018 May 21. pii: S1552-5260(18)30126.
    PubMed     Text format     Abstract available


  9. JOHANSSON JU, Brubaker WD, Javitz H, Bergen AW, et al
    Peripheral complement interactions with amyloid beta peptide in Alzheimer's disease: Polymorphisms, structure, and function of complement receptor 1.
    Alzheimers Dement. 2018 May 21. pii: S1552-5260(18)30125.
    PubMed     Text format     Abstract available


  10. SAEED U, Mirza SS, MacIntosh BJ, Herrmann N, et al
    APOE-epsilon4 associates with hippocampal volume, learning, and memory across the spectrum of Alzheimer's disease and dementia with Lewy bodies.
    Alzheimers Dement. 2018 May 18. pii: S1552-5260(18)30127.
    PubMed     Text format     Abstract available


  11. IWATSUBO T, Iwata A, Suzuki K, Ihara R, et al
    Japanese and North American Alzheimer's Disease Neuroimaging Initiative studies: Harmonization for international trials.
    Alzheimers Dement. 2018 May 8. pii: S1552-5260(18)30102.
    PubMed     Text format     Abstract available


  12. BROOKMEYER R, Abdalla N
    Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease.
    Alzheimers Dement. 2018 May 7. pii: S1552-5260(18)30098.
    PubMed     Text format     Abstract available


  13. LI P, Yu L, Lim ASP, Buchman AS, et al
    Fractal regulation and incident Alzheimer's disease in elderly individuals.
    Alzheimers Dement. 2018 May 4. pii: S1552-5260(18)30108.
    PubMed     Text format     Abstract available


    April 2018
  14. MIELKE MM, Hagen CE, Xu J, Chai X, et al
    Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography.
    Alzheimers Dement. 2018 Apr 4. pii: S1552-5260(18)30067.
    PubMed     Text format     Abstract available


  15. SILVERBERG N, Elliott C, Ryan L, Masliah E, et al
    NIA commentary on the NIA-AA Research Framework: Towards a biological definition of Alzheimer's disease.
    Alzheimers Dement. 2018;14:576-578.
    PubMed     Text format    


  16. KNOPMAN DS, Haeberlein SB, Carrillo MC, Hendrix JA, et al
    The National Institute on Aging and the Alzheimer's Association Research Framework for Alzheimer's disease: Perspectives from the Research Roundtable.
    Alzheimers Dement. 2018;14:563-575.
    PubMed     Text format     Abstract available


  17. JACK CR JR., Bennett DA, Blennow K, Carrillo MC, et al
    NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Alzheimers Dement. 2018;14:535-562.
    PubMed     Text format     Abstract available


  18. KHACHATURIAN AS, Hayden KM, Mielke MM, Tang Y, et al
    Future prospects and challenges for Alzheimer's disease drug development in the era of the NIA-AA Research Framework.
    Alzheimers Dement. 2018;14:532-534.
    PubMed     Text format    


    March 2018
  19. WHITWELL JL, Graff-Radford J, Tosakulwong N, Weigand SD, et al
    Imaging correlations of tau, amyloid, metabolism, and atrophy in typical and atypical Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 29. pii: S1552-5260(18)30074.
    PubMed     Text format     Abstract available


  20. DARWEESH SKL, Wolters FJ, Ikram MA, de Wolf F, et al
    Inflammatory markers and the risk of dementia and Alzheimer's disease: A meta-analysis.
    Alzheimers Dement. 2018 Mar 29. pii: S1552-5260(18)30068.
    PubMed     Text format     Abstract available


  21. VERMUNT L, Veal CD, Meulen LT, Chrysostomou C, et al
    European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials.
    Alzheimers Dement. 2018 Mar 28. pii: S1552-5260(18)30064.
    PubMed     Text format     Abstract available


  22. SHI M, Tang L, Toledo JB, Ginghina C, et al
    Cerebrospinal fluid alpha-synuclein contributes to the differential diagnosis of Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 28. pii: S1552-5260(18)30069.
    PubMed     Text format     Abstract available


  23. CACCIAGLIA R, Molinuevo JL, Falcon C, Brugulat-Serrat A, et al
    Effects of APOE-epsilon4 allele load on brain morphology in a cohort of middle-aged healthy individuals with enriched genetic risk for Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 27. pii: S1552-5260(18)30044.
    PubMed     Text format     Abstract available


  24. MATTSSON N, Groot C, Jansen WJ, Landau S, et al
    Prevalence of the apolipoprotein E epsilon4 allele in amyloid beta positive subjects across the spectrum of Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 27. pii: S1552-5260(18)30063.
    PubMed     Text format     Abstract available


  25. SUTPHEN CL, McCue L, Herries EM, Xiong C, et al
    Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 23. pii: S1552-5260(18)30031.
    PubMed     Text format     Abstract available


  26. GOLDMAN DP, Fillit H, Neumann P
    Accelerating Alzheimer's disease drug innovations from the research pipeline to patients.
    Alzheimers Dement. 2018 Mar 23. pii: S1552-5260(18)30050.
    PubMed     Text format     Abstract available


  27. STITES SD, Rubright JD, Karlawish J
    What features of stigma do the public most commonly attribute to Alzheimer's disease dementia? Results of a survey of the U.S. general public.
    Alzheimers Dement. 2018 Mar 17. pii: S1552-5260(18)30025.
    PubMed     Text format     Abstract available


  28. SMITH RG, Hannon E, De Jager PL, Chibnik L, et al
    Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer's disease neuropathology.
    Alzheimers Dement. 2018 Mar 14. pii: S1552-5260(18)30049.
    PubMed     Text format     Abstract available


  29. CONNORS MH, Seeher KM, Crawford J, Ames D, et al
    The stability of neuropsychiatric subsyndromes in Alzheimer's disease.
    Alzheimers Dement. 2018 Mar 13. pii: S1552-5260(18)30048.
    PubMed     Text format     Abstract available


  30. CHIBA-FALEK O, Gottschalk WK, Lutz MW
    The effects of the TOMM40 poly-T alleles on Alzheimer's disease phenotypes.
    Alzheimers Dement. 2018 Mar 7. pii: S1552-5260(18)30043.
    PubMed     Text format     Abstract available


    February 2018
  31. TYNKKYNEN J, Chouraki V, van der Lee SJ, Hernesniemi J, et al
    Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts.
    Alzheimers Dement. 2018 Feb 28. pii: S1552-5260(18)30020.
    PubMed     Text format     Abstract available


  32. HANSSON O, Seibyl J, Stomrud E, Zetterberg H, et al
    CSF biomarkers of Alzheimer's disease concord with amyloid-beta PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.
    Alzheimers Dement. 2018 Feb 27. pii: S1552-5260(18)30029.
    PubMed     Text format     Abstract available


  33. AHMAD S, Bannister C, van der Lee SJ, Vojinovic D, et al
    Disentangling the biological pathways involved in early features of Alzheimer's disease in the Rotterdam Study.
    Alzheimers Dement. 2018 Feb 26. pii: S1552-5260(18)30024.
    PubMed     Text format     Abstract available


  34. COHEN AD, McDade E, Christian B, Price J, et al
    Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition.
    Alzheimers Dement. 2018 Feb 22. pii: S1552-5260(18)30019.
    PubMed     Text format     Abstract available


  35. HANON O, Vidal JS, Lehmann S, Bombois S, et al
    Plasma amyloid levels within the Alzheimer's process and correlations with central biomarkers.
    Alzheimers Dement. 2018 Feb 16. pii: S1552-5260(18)30021.
    PubMed     Text format     Abstract available


  36. KNOPMAN DS, Siemers ER, Bain LJ, Hendrix JA, et al
    National Institute on Aging - Alzheimer's Association Research Framework lays the groundwork for deeper understanding of Alzheimer's disease.
    Alzheimers Dement. 2018;14:261-262.
    PubMed     Text format    


    January 2018
  37. MIRON J, Picard C, Nilsson N, Frappier J, et al
    CDK5RAP2 gene and tau pathophysiology in late-onset sporadic Alzheimer's disease.
    Alzheimers Dement. 2018 Jan 19. pii: S1552-5260(17)33875.
    PubMed     Text format     Abstract available


  38. DI GUARDO G
    Alzheimer's disease, cellular prion protein, and dolphins.
    Alzheimers Dement. 2018 Jan 15. pii: S1552-5260(17)33873.
    PubMed     Text format    


  39. JIA J, Wei C, Chen S, Li F, et al
    The cost of Alzheimer's disease in China and re-estimation of costs worldwide.
    Alzheimers Dement. 2018 Jan 11. pii: S1552-5260(17)33877.
    PubMed     Text format     Abstract available


  40. HAMPEL H, Toschi N, Baldacci F, Zetterberg H, et al
    Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Abeta1-42, total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40.
    Alzheimers Dement. 2018 Jan 9. pii: S1552-5260(17)33872.
    PubMed     Text format     Abstract available


  41. TSE KH, Cheng A, Ma F, Herrup K, et al
    DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's and dementia.
    Alzheimers Dement. 2018 Jan 9. pii: S1552-5260(17)33853.
    PubMed     Text format     Abstract available


  42. ACOSTA D, Powell F, Zhao Y, Raj A, et al
    Regional vulnerability in Alzheimer's: The role of cell-autonomous and transneuronal processes.
    Alzheimers Dement. 2018 Jan 4. pii: S1552-5260(17)33857.
    PubMed     Text format     Abstract available


  43. LI K, O'Brien R, Lutz M, Luo S, et al
    A prognostic model of Alzheimer's disease relying on multiple longitudinal measures and time-to-event data.
    Alzheimers Dement. 2018 Jan 3. pii: S1552-5260(17)33840.
    PubMed     Text format     Abstract available


    December 2017
  44. HALL H, Iulita MF, Gubert P, Aguilar LF, et al
    AF710B, an M1/sigma-1 receptor agonist with long-lasting disease-modifying properties in a transgenic rat model of Alzheimer's disease.
    Alzheimers Dement. 2017 Dec 29. pii: S1552-5260(17)33851.
    PubMed     Text format     Abstract available


  45. CHUNG J, Wang X, Maruyama T, Ma Y, et al
    Genome-wide association study of Alzheimer's disease endophenotypes at prediagnosis stages.
    Alzheimers Dement. 2017 Dec 20. pii: S1552-5260(17)33842.
    PubMed     Text format     Abstract available


  46. LEUZY A, Rodriguez-Vieitez E, Saint-Aubert L, Chiotis K, et al
    Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease.
    Alzheimers Dement. 2017 Dec 18. pii: S1552-5260(17)33844.
    PubMed     Text format     Abstract available


  47. BECKER RE, Kapogiannis D, Greig NH
    Does traumatic brain injury hold the key to the Alzheimer's puzzle?
    Alzheimers Dement. 2017 Dec 12. pii: S1552-5260(17)33843.
    PubMed     Text format     Abstract available


  48. PASPALAS CD, Carlyle BC, Leslie S, Preuss TM, et al
    The aged rhesus macaque manifests Braak stage III/IV Alzheimer's-like pathology.
    Alzheimers Dement. 2017 Dec 11. pii: S1552-5260(17)33841.
    PubMed     Text format     Abstract available


    November 2017
  49. BROOKMEYER R, Abdalla N, Kawas CH, Corrada MM, et al
    Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States.
    Alzheimers Dement. 2017 Nov 29. pii: S1552-5260(17)33813.
    PubMed     Text format     Abstract available


  50. STEFANIAK JD, Su L, Mak E, Bahaei NS, et al
    Cerebral small vessel disease in middle age and genetic predisposition to late-onset Alzheimer's disease.
    Alzheimers Dement. 2017 Nov 18. pii: S1552-5260(17)33809.
    PubMed     Text format     Abstract available


  51. VIDONI ED, Bothwell RJ, Burns JM, Dwyer JR, et al
    Novel recruitment models will drive Alzheimer's trial success.
    Alzheimers Dement. 2017 Nov 17. pii: S1552-5260(17)33793.
    PubMed     Text format    


    October 2017
  52. MONTAL V, Vilaplana E, Alcolea D, Pegueroles J, et al
    Cortical microstructural changes along the Alzheimer's disease continuum.
    Alzheimers Dement. 2017 Oct 31. pii: S1552-5260(17)33767.
    PubMed     Text format     Abstract available


  53. ALLEN M, Wang X, Burgess JD, Watzlawik J, et al
    Conserved brain myelination networks are altered in Alzheimer's and other neurodegenerative diseases.
    Alzheimers Dement. 2017 Oct 26. pii: S1552-5260(17)33766.
    PubMed     Text format     Abstract available


  54. CRANE PK, Foroud T, Montine TJ, Larson EB, et al
    Alzheimer's Disease Sequencing Project discovery and replication criteria for cases and controls: Data from a community-based prospective cohort study with autopsy follow-up.
    Alzheimers Dement. 2017 Oct 19. pii: S1552-5260(17)33764.
    PubMed     Text format     Abstract available


  55. AN Y, Varma VR, Varma S, Casanova R, et al
    Evidence for brain glucose dysregulation in Alzheimer's disease.
    Alzheimers Dement. 2017 Oct 19. pii: S1552-5260(17)33765.
    PubMed     Text format     Abstract available


  56. HAMPEL H, Mesulam MM, Cuello AC, Khachaturian AS, et al
    Revisiting the cholinergic hypothesis in Alzheimer's disease: Emerging evidence from translational and clinical research.
    Alzheimers Dement. 2017 Oct 10. pii: S1552-5260(17)33719.
    PubMed     Text format     Abstract available


    September 2017
  57. GUNN-MOORE D, Kaidanovich-Beilin O, Gallego Iradi MC, Gunn-Moore F, et al
    Alzheimer's disease in humans and other animals-A consequence of postreproductive life span and longevity rather than aging.
    Alzheimers Dement. 2017 Sep 30. pii: S1552-5260(17)33717.
    PubMed     Text format     Abstract available


  58. CRUCHAGA C, Del-Aguila JL, Saef B, Black K, et al
    Polygenic risk score of sporadic late-onset Alzheimer's disease reveals a shared architecture with the familial and early-onset forms.
    Alzheimers Dement. 2017 Sep 21. pii: S1552-5260(17)33708.
    PubMed     Text format     Abstract available


  59. XU M, Zhang DF, Luo R, Wu Y, et al
    A systematic integrated analysis of brain expression profiles reveals YAP1 and other prioritized hub genes as important upstream regulators in Alzheimer's disease.
    Alzheimers Dement. 2017 Sep 15. pii: S1552-5260(17)33707.
    PubMed     Text format     Abstract available


  60. GEERTS H, Hofmann-Apitius M, Anastasio TJ
    Knowledge-driven computational modeling in Alzheimer's research: Current state and future trends.
    Alzheimers Dement. 2017 Sep 14. pii: S1552-5260(17)33690.
    PubMed     Text format     Abstract available


  61. LIN PJ, Zhong Y, Fillit HM, Cohen JT, et al
    Hospitalizations for ambulatory care sensitive conditions and unplanned readmissions among Medicare beneficiaries with Alzheimer's disease.
    Alzheimers Dement. 2017 Sep 5. pii: S1552-5260(17)33687.
    PubMed     Text format     Abstract available


    August 2017
  62. KNOPMAN D, Alford E, Tate K, Long M, et al
    Patients come from populations and populations contain patients. A two-stage scientific and ethics review: The next adaptation for single institutional review boards.
    Alzheimers Dement. 2017;13:940-946.
    PubMed     Text format     Abstract available


  63. WOLF D, Bocchetta M, Preboske GM, Boccardi M, et al
    Reference standard space hippocampus labels according to the European Alzheimer's Disease Consortium-Alzheimer's Disease Neuroimaging Initiative harmonized protocol: Utility in automated volumetry.
    Alzheimers Dement. 2017;13:893-902.
    PubMed     Text format     Abstract available


  64. GRILL JD, Cox CG, Kremen S, Mendez MF, et al
    Patient and caregiver reactions to clinical amyloid imaging.
    Alzheimers Dement. 2017;13:924-932.
    PubMed     Text format     Abstract available


    July 2017
  65. CRANE A, Brubaker WD, Johansson JU, Trigunaite A, et al
    Peripheral complement interactions with amyloid beta peptide in Alzheimer's disease: 2. Relationship to Abeta immunotherapy.
    Alzheimers Dement. 2017 Jul 26. pii: S1552-5260(17)32898.
    PubMed     Text format     Abstract available


  66. LUTSEY PL, Misialek JR, Mosley TH, Gottesman RF, et al
    Sleep characteristics and risk of dementia and Alzheimer's disease: The Atherosclerosis Risk in Communities Study.
    Alzheimers Dement. 2017 Jul 21. pii: S1552-5260(17)32522.
    PubMed     Text format     Abstract available


  67. KINNUNEN KM, Cash DM, Poole T, Frost C, et al
    Presymptomatic atrophy in autosomal dominant Alzheimer's disease: A serial MRI study.
    Alzheimers Dement. 2017 Jul 21. pii: S1552-5260(17)32521.
    PubMed     Text format     Abstract available


  68. FRAIN L, Swanson D, Cho K, Gagnon D, et al
    Association of cancer and Alzheimer's disease risk in a national cohort of veterans.
    Alzheimers Dement. 2017 Jul 12. pii: S1552-5260(17)30218.
    PubMed     Text format     Abstract available


  69. BURGGREN AC, Mahmood Z, Harrison TM, Siddarth P, et al
    Hippocampal thinning linked to longer TOMM40 poly-T variant lengths in the absence of the APOE epsilon4 variant.
    Alzheimers Dement. 2017;13:739-748.
    PubMed     Text format     Abstract available


    June 2017
  70. CRANE PK, Trittschuh E, Mukherjee S, Saykin AJ, et al
    Incidence of cognitively defined late-onset Alzheimer's dementia subgroups from a prospective cohort study.
    Alzheimers Dement. 2017 Jun 14. pii: S1552-5260(17)30216.
    PubMed     Text format     Abstract available


  71. DRACHMAN DA, Smith TW, Alkamachi B, Kane K, et al
    Microvascular changes in Down syndrome with Alzheimer-type pathology: Insights into a potential vascular mechanism for Down syndrome and Alzheimer's disease.
    Alzheimers Dement. 2017 Jun 13. pii: S1552-5260(17)30219.
    PubMed     Text format     Abstract available


  72. CHOURAKI V, Preis SR, Yang Q, Beiser A, et al
    Association of amine biomarkers with incident dementia and Alzheimer's disease in the Framingham Study.
    Alzheimers Dement. 2017 Jun 8. pii: S1552-5260(17)30200.
    PubMed     Text format     Abstract available


  73. TOLPPANEN AM, Taipale H, Hartikainen S
    Head or brain injuries and Alzheimer's disease: A nested case-control register study.
    Alzheimers Dement. 2017 Jun 6. pii: S1552-5260(17)30201.
    PubMed     Text format     Abstract available


  74. PASCOAL TA, Mathotaarachchi S, Shin M, Benedet AL, et al
    Synergistic interaction between amyloid and tau predicts the progression to dementia.
    Alzheimers Dement. 2017;13:644-653.
    PubMed     Text format     Abstract available


  75. BRENOWITZ WD, Hubbard RA, Keene CD, Hawes SE, et al
    Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample.
    Alzheimers Dement. 2017;13:654-662.
    PubMed     Text format     Abstract available


  76. SCHELLE J, Hasler LM, Gopfert JC, Joos TO, et al
    Prevention of tau increase in cerebrospinal fluid of APP transgenic mice suggests downstream effect of BACE1 inhibition.
    Alzheimers Dement. 2017;13:701-709.
    PubMed     Text format     Abstract available


    May 2017
  77. BROWN BM, Sohrabi HR, Taddei K, Gardener SL, et al
    Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease.
    Alzheimers Dement. 2017 May 11. pii: S1552-5260(17)30147.
    PubMed     Text format     Abstract available


  78. WILLETTE AA, Webb JL, Lutz MW, Bendlin BB, et al
    Family history and TOMM40 '523 interactive associations with memory in middle-aged and Alzheimer's disease cohorts.
    Alzheimers Dement. 2017 May 10. pii: S1552-5260(17)30148.
    PubMed     Text format     Abstract available


  79. FEART C, Helmer C, Merle B, Herrmann FR, et al
    Associations of lower vitamin D concentrations with cognitive decline and long-term risk of dementia and Alzheimer's disease in older adults.
    Alzheimers Dement. 2017 May 9. pii: S1552-5260(17)30138.
    PubMed     Text format     Abstract available


  80. BRUBAKER WD, Crane A, Johansson JU, Yen K, et al
    Peripheral complement interactions with amyloid beta peptides in Alzheimer's disease: Erythrocyte clearance of amyloid beta peptides.
    Alzheimers Dement. 2017 May 2. pii: S1552-5260(17)30149.
    PubMed     Text format     Abstract available


    April 2017
  81. CARMONA-IRAGUI M, Balasa M, Benejam B, Alcolea D, et al
    Cerebral amyloid angiopathy in Down syndrome and sporadic and autosomal-dominant Alzheimer's disease.
    Alzheimers Dement. 2017 Apr 29. pii: S1552-5260(17)30146.
    PubMed     Text format     Abstract available


  82. CARRILLO MC, Fillit H, Ganguli M, Knopman D, et al
    Letter to the Editor re: Nexus of Cancer & Alzheimer's.
    Alzheimers Dement. 2017 Apr 19. pii: S1552-5260(17)30142.
    PubMed     Text format    


  83. SCHELTENS NME, Tijms BM, Koene T, Barkhof F, et al
    Cognitive subtypes of probable Alzheimer's disease robustly identified in four cohorts.
    Alzheimers Dement. 2017 Apr 17. pii: S1552-5260(17)30137.
    PubMed     Text format     Abstract available


    March 2017
  84. RITCHIE K, Carriere I, Su L, O'Brien JT, et al
    The midlife cognitive profiles of adults at high risk of late-onset Alzheimer's disease: The PREVENT study.
    Alzheimers Dement. 2017 Mar 29. pii: S1552-5260(17)30093.
    PubMed     Text format     Abstract available


  85. NIELSEN RB, Egefjord L, Angleys H, Mouridsen K, et al
    Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease.
    Alzheimers Dement. 2017 Mar 23. pii: S1552-5260(17)30092.
    PubMed     Text format     Abstract available


  86. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.
    Alzheimers Dement. 2017 Mar 22. pii: S1552-5260(16)33124.
    PubMed     Text format     Abstract available


  87. ROCKWOOD K, Howlett SE, Hoffman D, Schindler R, et al
    Clinical meaningfulness of Alzheimer's Disease Assessment Scale-Cognitive subscale change in relation to goal attainment in patients on cholinesterase inhibitors.
    Alzheimers Dement. 2017 Mar 21. pii: S1552-5260(17)30090.
    PubMed     Text format     Abstract available


  88. TOLEDO JB, Arnold M, Kastenmuller G, Chang R, et al
    Metabolic network failures in Alzheimer's disease-A biochemical road map.
    Alzheimers Dement. 2017 Mar 21. pii: S1552-5260(17)30046.
    PubMed     Text format     Abstract available


  89. KARLAWISH J, Jack CR Jr, Rocca WA, Snyder HM, et al
    Alzheimer's disease: The next frontier-Special Report 2017.
    Alzheimers Dement. 2017 Mar 14. pii: S1552-5260(17)30091.
    PubMed     Text format     Abstract available


  90. KARAGEORGIOU E, Vossel KA
    Brain rhythm attractor breakdown in Alzheimer's disease: Functional and pathologic implications.
    Alzheimers Dement. 2017 Mar 13. pii: S1552-5260(17)30061.
    PubMed     Text format     Abstract available


  91. PASE MP, Himali JJ, Jacques PF, DeCarli C, et al
    Sugary beverage intake and preclinical Alzheimer's disease in the community.
    Alzheimers Dement. 2017 Mar 5. pii: S1552-5260(17)30050.
    PubMed     Text format     Abstract available


  92. BALDACCI F, Toschi N, Lista S, Zetterberg H, et al
    Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease.
    Alzheimers Dement. 2017 Mar 2. pii: S1552-5260(17)30047.
    PubMed     Text format     Abstract available


  93. BOSCO P, Redolfi A, Bocchetta M, Ferrari C, et al
    The impact of automated hippocampal volumetry on diagnostic confidence in patients with suspected Alzheimer's disease: An EADC study.
    Alzheimers Dement. 2017 Mar 2. pii: S1552-5260(17)30045.
    PubMed     Text format     Abstract available


  94. WEINTRAUB S, Randolph C, Bain L, Hendrix JA, et al
    Is cognitive decline measurable in preclinical Alzheimer's disease?
    Alzheimers Dement. 2017;13:322-323.
    PubMed     Text format    


  95. HERUKKA SK, Simonsen AH, Andreasen N, Baldeiras I, et al
    Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment.
    Alzheimers Dement. 2017;13:285-295.
    PubMed     Text format     Abstract available


  96. SIMONSEN AH, Herukka SK, Andreasen N, Baldeiras I, et al
    Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia.
    Alzheimers Dement. 2017;13:274-284.
    PubMed     Text format     Abstract available


  97. TON TGN, DeLeire T, May SG, Hou N, et al
    The financial burden and health care utilization patterns associated with amnestic mild cognitive impairment.
    Alzheimers Dement. 2017;13:217-224.
    PubMed     Text format     Abstract available


    February 2017
  98. MORMINO EC, Papp KV, Rentz DM, Donohue MC, et al
    Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated beta-amyloid.
    Alzheimers Dement. 2017 Feb 27. pii: S1552-5260(17)30044.
    PubMed     Text format     Abstract available


  99. KIN WONG MW, Braidy N, Poljak A, Pickford R, et al
    Dysregulation of lipids in Alzheimer's disease and their role as potential biomarkers.
    Alzheimers Dement. 2017 Feb 24. pii: S1552-5260(17)30012.
    PubMed     Text format     Abstract available


  100. MUKHERJEE S, Russell JC, Carr DT, Burgess JD, et al
    Systems biology approach to late-onset Alzheimer's disease genome-wide association study identifies novel candidate genes validated using brain expression data and Caenorhabditis elegans experiments.
    Alzheimers Dement. 2017 Feb 24. pii: S1552-5260(17)30042.
    PubMed     Text format     Abstract available


  101. JIA J, Gauthier S, Pallotta S, Ji Y, et al
    Consensus-based recommendations for the management of rapid cognitive decline due to Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 23. pii: S1552-5260(17)30011.
    PubMed     Text format     Abstract available


  102. JONSSON L, Lin PJ, Khachaturian AS
    Special topic section on health economics and public policy of Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 20. pii: S1552-5260(17)30085.
    PubMed     Text format    


  103. FARDO DW, Gibbons LE, Mukherjee S, Glymour MM, et al
    Impact of home visit capacity on genetic association studies of late-onset Alzheimer's disease.
    Alzheimers Dement. 2017 Feb 18. pii: S1552-5260(17)30018.
    PubMed     Text format     Abstract available


  104. TEICHMANN M, Epelbaum S, Samri D, Levy Nogueira M, et al
    Free and Cued Selective Reminding Test-accuracy for Alzheimer's and neurodegenerative disease differential diagnosis: A large-scale biomarker-characterized monocenter cohort study (ClinAD).
    Alzheimers Dement. 2017 Feb 18. pii: S1552-5260(17)30014.
    PubMed     Text format     Abstract available


  105. OBOUDIYAT C, Gefen T, Varelas E, Weintraub S, et al
    Cerebrospinal fluid markers detect Alzheimer's disease in nonamnestic dementia.
    Alzheimers Dement. 2017 Feb 11. pii: S1552-5260(17)30010.
    PubMed     Text format     Abstract available


  106. EPELBAUM S, Genthon R, Cavedo E, Habert MO, et al
    Preclinical Alzheimer's disease: A systematic review of the cohorts underlying the concept.
    Alzheimers Dement. 2017 Feb 7. pii: S1552-5260(16)33123.
    PubMed     Text format     Abstract available


  107. JUN GR, Chung J, Mez J, Barber R, et al
    Transethnic genome-wide scan identifies novel Alzheimer's disease loci.
    Alzheimers Dement. 2017 Feb 6. pii: S1552-5260(17)30003.
    PubMed     Text format     Abstract available


  108. SPOSATO LA, Ruiz Vargas E, Riccio PM, Toledo JB, et al
    Milder Alzheimer's disease pathology in heart failure and atrial fibrillation.
    Alzheimers Dement. 2017 Feb 4. pii: S1552-5260(16)33122.
    PubMed     Text format     Abstract available


  109. OVERK C, Masliah E
    Perspective on the calcium dyshomeostasis hypothesis in the pathogenesis of selective neuronal degeneration in animal models of Alzheimer's disease.
    Alzheimers Dement. 2017;13:183-185.
    PubMed     Text format    


    January 2017
  110. NESTOR SM, Misic B, Ramirez J, Zhao J, et al
    Small vessel disease is linked to disrupted structural network covariance in Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 27. pii: S1552-5260(16)33128.
    PubMed     Text format     Abstract available


  111. LLINAS R, Moreno H
    Perspective on calcium and Alzheimer disease.
    Alzheimers Dement. 2017 Jan 25. pii: S1552-5260(17)30008.
    PubMed     Text format    


  112. LOVHEIM H, Elgh F, Johansson A, Zetterberg H, et al
    Plasma concentrations of free amyloid beta cannot predict the development of Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 7. pii: S1552-5260(16)33125.
    PubMed     Text format     Abstract available


  113. ZHAO J, Zhu Y, Yang J, Li L, et al
    A genome-wide profiling of brain DNA hydroxymethylation in Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 6. pii: S1552-5260(16)33059.
    PubMed     Text format     Abstract available


  114. GUSTAVSSON A, Green C, Jones RW, Forstl H, et al
    Current issues and future research priorities for health economic modelling across the full continuum of Alzheimer's disease.
    Alzheimers Dement. 2017 Jan 4. pii: S1552-5260(16)33126.
    PubMed     Text format     Abstract available



  115. Calcium Hypothesis of Alzheimer's disease and brain aging: A framework for integrating new evidence into a comprehensive theory of pathogenesis.
    Alzheimers Dement. 2017 Jan 3. pii: S1552-5260(16)33127.
    PubMed     Text format     Abstract available


    December 2016
  116. DODGE HH, Zhu J, Woltjer R, Nelson PT, et al
    Risk of incident clinical diagnosis of Alzheimer's disease-type dementia attributable to pathology-confirmed vascular disease.
    Alzheimers Dement. 2016 Dec 22. pii: S1552-5260(16)33091.
    PubMed     Text format     Abstract available


  117. SNYDER HM, Ahles T, Calderwood S, Carrillo MC, et al
    Exploring the nexus of Alzheimer's disease and related dementias with cancer and cancer therapies.
    Alzheimers Dement. 2016 Dec 17. pii: S1552-5260(16)33090.
    PubMed     Text format     Abstract available


  118. CARRASQUILLO MM, Allen M, Burgess JD, Wang X, et al
    A candidate regulatory variant at the TREM gene cluster associates with decreased Alzheimer's disease risk and increased TREML1 and TREM2 brain gene expression.
    Alzheimers Dement. 2016 Dec 8. pii: S1552-5260(16)33071.
    PubMed     Text format     Abstract available


  119. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    The Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement.
    Alzheimers Dement. 2016 Dec 5. pii: S1552-5260(16)33072.
    PubMed     Text format     Abstract available


    November 2016
  120. CRONIN P, McCarthy MJ, Lim AS, Salmon DP, et al
    Circadian alterations during early stages of Alzheimer's disease are associated with aberrant cycles of DNA methylation in BMAL1.
    Alzheimers Dement. 2016 Nov 21. pii: S1552-5260(16)33058.
    PubMed     Text format     Abstract available


  121. O'BRYANT SE, Mielke MM, Rissman RA, Lista S, et al
    Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.
    Alzheimers Dement. 2016 Nov 18. pii: S1552-5260(16)33056.
    PubMed     Text format     Abstract available


  122. SNYDER HM, Shineman DW, Friedman LG, Hendrix JA, et al
    Guidelines to improve animal study design and reproducibility for Alzheimer's disease and related dementias: For funders and researchers.
    Alzheimers Dement. 2016;12:1177-1185.
    PubMed     Text format     Abstract available


  123. FARGO KN, Carrillo MC, Weiner MW, Potter WZ, et al
    The crisis in recruitment for clinical trials in Alzheimer's and dementia: An action plan for solutions.
    Alzheimers Dement. 2016;12:1113-1115.
    PubMed     Text format    


    October 2016
  124. MASTROENI D, Khdour OM, Delvaux E, Nolz J, et al
    Nuclear but not mitochondrial-encoded OXPHOS genes are altered in aging, mild cognitive impairment, and Alzheimer's disease.
    Alzheimers Dement. 2016 Oct 25. pii: S1552-5260(16)32932.
    PubMed     Text format     Abstract available


  125. MEZ J, Chung J, Jun G, Kriegel J, et al
    Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans.
    Alzheimers Dement. 2016 Oct 19. pii: S1552-5260(16)32931.
    PubMed     Text format     Abstract available


  126. HAMLETT ED, Goetzl EJ, Ledreux A, Vasilevko V, et al
    Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome.
    Alzheimers Dement. 2016 Oct 15. pii: S1552-5260(16)32892.
    PubMed     Text format     Abstract available


  127. LAM B, Khan A, Keith J, Rogaeva E, et al
    Characterizing familial corticobasal syndrome due to Alzheimer's pathology and PSEN1 mutations.
    Alzheimers Dement. 2016 Oct 12. pii: S1552-5260(16)32894.
    PubMed     Text format     Abstract available


  128. RITCHIE K, Ropacki M, Albala B, Harrison J, et al
    Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project.
    Alzheimers Dement. 2016 Oct 1. pii: S1552-5260(16)32902.
    PubMed     Text format     Abstract available


  129. MORTAMAIS M, Ash JA, Harrison J, Kaye J, et al
    Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility.
    Alzheimers Dement. 2016 Oct 1. pii: S1552-5260(16)32901.
    PubMed     Text format     Abstract available


    September 2016
  130. JACK CR, Wiste HJ, Weigand SD, Therneau TM, et al
    Defining imaging biomarker cut points for brain aging and Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 30. pii: S1552-5260(16)32875.
    PubMed     Text format     Abstract available


  131. PEGUEROLES J, Vilaplana E, Montal V, Sampedro F, et al
    Longitudinal brain structural changes in preclinical Alzheimer disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32890.
    PubMed     Text format     Abstract available


  132. NORAMBUENA A, Wallrabe H, McMahon L, Silva A, et al
    mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32895.
    PubMed     Text format     Abstract available


  133. PROITSI P, Kim M, Whiley L, Simmons A, et al
    Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)30022.
    PubMed     Text format     Abstract available


  134. LOVHEIM H, Elgh F, Johansson A, Zetterberg H, et al
    Plasma concentrations of free amyloid-beta cannot predict the development of Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)32896.
    PubMed     Text format     Abstract available


  135. NI R, Gillberg PG, Bogdanovic N, Viitanen M, et al
    Amyloid tracers binding sites in autosomal dominant and sporadic Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 28. pii: S1552-5260(16)30141.
    PubMed     Text format     Abstract available


  136. LEEUWIS AE, Benedictus MR, Kuijer JP, Binnewijzend MA, et al
    Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's disease.
    Alzheimers Dement. 2016 Sep 27. pii: S1552-5260(16)32893.
    PubMed     Text format     Abstract available


  137. SNYDER HM, Asthana S, Bain L, Brinton R, et al
    Sex biology contributions to vulnerability to Alzheimer's disease: A think tank convened by the Women's Alzheimer's Research Initiative.
    Alzheimers Dement. 2016 Sep 21. pii: S1552-5260(16)32874.
    PubMed     Text format     Abstract available


  138. LANCTOT KL, Boot BP, Bain LJ, Hendrix JA, et al
    Considering new treatment paradigms for neuropsychiatric symptoms of Alzheimer's disease.
    Alzheimers Dement. 2016;12:1031-2.
    PubMed     Text format    


    August 2016
  139. BATEMAN RJ, Benzinger TL, Berry S, Clifford DB, et al
    The DIAN-TU Next Generation Alzheimer's prevention trial: Adaptive design and disease progression model.
    Alzheimers Dement. 2016 Aug 29. pii: S1552-5260(16)30048.
    PubMed     Text format     Abstract available


  140. SARRO L, Tosakulwong N, Schwarz CG, Graff-Radford J, et al
    An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease.
    Alzheimers Dement. 2016 Aug 10. pii: S1552-5260(16)32682.
    PubMed     Text format     Abstract available


  141. SONG W, Hooli B, Mullin K, Jin SC, et al
    Alzheimer's disease-associated TREM2 variants exhibit either decreased or increased ligand-dependent activation.
    Alzheimers Dement. 2016 Aug 9. pii: S1552-5260(16)30203.
    PubMed     Text format     Abstract available


  142. THEOFILAS P, Ehrenberg AJ, Dunlop S, Alho AT, et al
    Locus coeruleus volume and cell population changes during Alzheimer's disease progression: A stereological study in human postmortem brains with potential implication for early-stage biomarker discovery.
    Alzheimers Dement. 2016 Aug 8. pii: S1552-5260(16)32679.
    PubMed     Text format     Abstract available


    July 2016
  143. TAYLOR AN, Kambeitz-Ilankovic L, Gesierich B, Simon-Vermot L, et al
    Tract-specific white matter hyperintensities disrupt neural network function in Alzheimer's disease.
    Alzheimers Dement. 2016 Jul 15. pii: S1552-5260(16)32660.
    PubMed     Text format     Abstract available


  144. GISPERT JD, Suarez-Calvet M, Monte GC, Tucholka A, et al
    Cerebrospinal fluid sTREM2 levels are associated with gray matter volume increases and reduced diffusivity in early Alzheimer's disease.
    Alzheimers Dement. 2016 Jul 13. pii: S1552-5260(16)30026.
    PubMed     Text format     Abstract available


  145. COLEY N, Gallini A, Ousset PJ, Vellas B, et al
    Evaluating the clinical relevance of a cognitive composite outcome measure: An analysis of 1414 participants from the 5-year GuidAge Alzheimer's prevention trial.
    Alzheimers Dement. 2016 Jul 13. pii: S1552-5260(16)30085.
    PubMed     Text format     Abstract available


    June 2016
  146. SNYDER PJ
    DADM: The first 2 years of the Alzheimer Association's open access journal to support the research and development of novel biomarkers and diagnostic approaches.
    Alzheimers Dement. 2016 Jun 28. pii: S1552-5260(16)30310.
    PubMed     Text format    


  147. SOBOL NA, Hoffmann K, Frederiksen KS, Vogel A, et al
    Effect of aerobic exercise on physical performance in patients with Alzheimer's disease.
    Alzheimers Dement. 2016 Jun 23. pii: S1552-5260(15)30002.
    PubMed     Text format     Abstract available


  148. CACERES A, Vargas JE, Gonzalez JR
    APOE and MS4A6A interact with GnRH signaling in Alzheimer's disease: Enrichment of epistatic effects.
    Alzheimers Dement. 2016 Jun 20. pii: S1552-5260(16)30283.
    PubMed     Text format     Abstract available


  149. HERRING A, Munster Y, Akkaya T, Moghaddam S, et al
    Kallikrein-8 inhibition attenuates Alzheimer's pathology in mice.
    Alzheimers Dement. 2016 Jun 18. pii: S1552-5260(16)30280.
    PubMed     Text format     Abstract available


  150. SUN X, Dong C, Levin B, Crocco E, et al
    APOE epsilon4 carriers may undergo synaptic damage conferring risk of Alzheimer's disease.
    Alzheimers Dement. 2016 Jun 16. pii: S1552-5260(16)30278.
    PubMed     Text format     Abstract available


  151. SNYDER HM, Cardenas-Aguayo Mdel C, Alonso A, Bain L, et al
    Alzheimer's disease research in Ibero America.
    Alzheimers Dement. 2016;12:749-54.
    PubMed     Text format    


    May 2016
  152. GEERTS H, Dacks PA, Devanarayan V, Haas M, et al
    From big data to smart data in Alzheimer's disease. The brain health modeling initiative to foster actionable knowledge.
    Alzheimers Dement. 2016 May 26. pii: S1552-5260(16)30246.
    PubMed     Text format     Abstract available


  153. SHI M, Kovac A, Korff A, Cook TJ, et al
    CNS tau efflux via exosomes is likely increased in Parkinson disease but not in Alzheimer disease.
    Alzheimers Dement. 2016 May 24. pii: S1552-5260(16)30242.
    PubMed     Text format     Abstract available


  154. BERECZKI E, Francis PT, Howlett D, Pereira JB, et al
    Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia.
    Alzheimers Dement. 2016 May 22. pii: S1552-5260(16)30244.
    PubMed     Text format     Abstract available


  155. CALSOLARO V, Edison P
    Neuroinflammation in Alzheimer's disease: Current evidence and future directions.
    Alzheimers Dement. 2016 May 11. pii: S1552-5260(16)30185.
    PubMed     Text format     Abstract available


  156. ROSES A, Sundseth S, Saunders A, Gottschalk W, et al
    Understanding the genetics of APOE and TOMM40 and role of mitochondrial structure and function in clinical pharmacology of Alzheimer's disease.
    Alzheimers Dement. 2016 May 3. pii: S1552-5260(16)30118.
    PubMed     Text format     Abstract available


  157. PRIOR M, Goldberg J, Chiruta C, Farrokhi C, et al
    Selecting for neurogenic potential as an alternative for Alzheimer's drug discovery.
    Alzheimers Dement. 2016 May 2. pii: S1552-5260(16)30117.
    PubMed     Text format     Abstract available


  158. WENINGER S, Carrillo MC, Dunn B, Aisen PS, et al
    Collaboration for Alzheimer's Prevention: Principles to guide data and sample sharing in preclinical Alzheimer's disease trials.
    Alzheimers Dement. 2016;12:631-2.
    PubMed     Text format    


    April 2016
  159. TOSUN D, Chen YF, Yu P, Sundell KL, et al
    Amyloid status imputed from a multimodal classifier including structural MRI distinguishes progressors from nonprogressors in a mild Alzheimer's disease clinical trial cohort.
    Alzheimers Dement. 2016 Apr 21. pii: S1552-5260(16)30192.
    PubMed     Text format     Abstract available


  160. GRAFF-RADFORD NR, Besser LM, Crook JE, Kukull WA, et al
    Neuropathologic differences by race from the National Alzheimer's Coordinating Center.
    Alzheimers Dement. 2016 Apr 16. pii: S1552-5260(16)30182.
    PubMed     Text format     Abstract available


  161. ALLEN GI, Amoroso N, Anghel C, Balagurusamy V, et al
    Crowdsourced estimation of cognitive decline and resilience in Alzheimer's disease.
    Alzheimers Dement. 2016 Apr 11. pii: S1552-5260(16)00081.
    PubMed     Text format     Abstract available


  162. RABINOVICI GD, Karlawish J, Knopman D, Snyder HM, et al
    Testing and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summary.
    Alzheimers Dement. 2016;12:510-5.
    PubMed     Text format     Abstract available



  163. 2016 Alzheimer's disease facts and figures.
    Alzheimers Dement. 2016;12:459-509.
    PubMed     Text format     Abstract available


  164. LIM YY, Maruff P, Getter C, Snyder PJ, et al
    Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability.
    Alzheimers Dement. 2016;12:454-8.
    PubMed     Text format     Abstract available


  165. CRANE PK, Gibbons LE, McCurry SM, McCormick W, et al
    Importance of home study visit capacity in dementia studies.
    Alzheimers Dement. 2016;12:419-26.
    PubMed     Text format     Abstract available


    March 2016
  166. HENDRIX JA, Bateman RJ, Brashear HR, Duggan C, et al
    Challenges, solutions, and recommendations for Alzheimer's disease combination therapy.
    Alzheimers Dement. 2016 Mar 24. pii: S1552-5260(16)00082.
    PubMed     Text format     Abstract available


  167. CACACE R, Sleegers K, Van Broeckhoven C
    Molecular genetics of early-onset Alzheimer disease revisited.
    Alzheimers Dement. 2016 Mar 23. pii: S1552-5260(16)00079.
    PubMed     Text format     Abstract available


  168. YU L, Chibnik L, Yang J, McCabe C, et al
    Methylation profiles in peripheral blood CD4+ lymphocytes versus brain: The relation to Alzheimer's disease pathology.
    Alzheimers Dement. 2016 Mar 23. pii: S1552-5260(16)00084.
    PubMed     Text format     Abstract available


  169. GREEN C, Zhang S
    Predicting the progression of Alzheimer's disease dementia: A multidomain health policy model.
    Alzheimers Dement. 2016 Mar 23. pii: S1552-5260(16)00078.
    PubMed     Text format     Abstract available


  170. SCHOTT JM, Crutch SJ, Carrasquillo MM, Uphill J, et al
    Genetic risk factors for the posterior cortical atrophy variant of Alzheimer's disease.
    Alzheimers Dement. 2016 Mar 15. pii: S1552-5260(16)00077.
    PubMed     Text format     Abstract available


  171. DI STEFANO F, Kas A, Habert MO, Decazes P, et al
    The phenotypical core of Alzheimer-related and nonrelated variants of the corticobasal syndrome: A systematic clinical, neuropsychological, imaging, and biomarker study.
    Alzheimers Dement. 2016 Mar 14. pii: S1552-5260(16)00075.
    PubMed     Text format     Abstract available


  172. MOLINUEVO JL, Cami J, Carne X, Carrillo MC, et al
    Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit.
    Alzheimers Dement. 2016 Mar 14. pii: S1552-5260(16)00076.
    PubMed     Text format     Abstract available


  173. DUBOIS B, Hampel H, Feldman HH, Scheltens P, et al
    Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.
    Alzheimers Dement. 2016;12:292-323.
    PubMed     Text format     Abstract available


  174. KHACHATURIAN ZS, Mesulam MM, Mohs RC, Khachaturian AS, et al
    Toward a consensus recommendation for defining the asymptomatic-preclinical phases of putative Alzheimer's disease?
    Alzheimers Dement. 2016;12:213-5.
    PubMed     Text format    


    February 2016
  175. RUIZ HH, Chi T, Lindtner C, Hsieh W, et al
    Increased susceptibility to metabolic dysregulation in a mouse model of Alzheimer's disease is associated with impaired hypothalamic insulin signaling and elevated BCAA levels.
    Alzheimers Dement. 2016 Feb 26. pii: S1552-5260(16)00049.
    PubMed     Text format     Abstract available


  176. LOUWERSHEIMER E, Wolfsgruber S, Espinosa A, Lacour A, et al
    Alzheimer's disease risk variants modulate endophenotypes in mild cognitive impairment.
    Alzheimers Dement. 2016 Feb 24. pii: S1552-5260(16)00046.
    PubMed     Text format     Abstract available


  177. THOMAS RG, Albert M, Petersen RC, Aisen PS, et al
    Longitudinal decline in mild-to-moderate Alzheimer's disease: Analyses of placebo data from clinical trials.
    Alzheimers Dement. 2016 Feb 22. pii: S1552-5260(16)00032.
    PubMed     Text format     Abstract available


  178. BROOKMEYER R, Kawas CH, Abdallah N, Paganini-Hill A, et al
    Impact of interventions to reduce Alzheimer disease pathology on the prevalence of dementia in the oldest-old.
    Alzheimers Dement. 2016 Feb 17. pii: S1552-5260(16)00034.
    PubMed     Text format     Abstract available


  179. SANDER K, Lashley T, Gami P, Gendron T, et al
    Characterization of tau positron emission tomography tracer [F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias.
    Alzheimers Dement. 2016 Feb 15. pii: S1552-5260(16)00033.
    PubMed     Text format     Abstract available


  180. BORSON S, Boustani MA, Buckwalter KC, Burgio LD, et al
    Report on milestones for care and support under the U.S. National Plan to Address Alzheimer's Disease.
    Alzheimers Dement. 2016 Feb 8. pii: S1552-5260(16)00035.
    PubMed     Text format     Abstract available


  181. BUCKLEY RF, Maruff P, Ames D, Bourgeat P, et al
    Subjective memory decline predicts greater rates of clinical progression in preclinical Alzheimer's disease.
    Alzheimers Dement. 2016 Feb 4. pii: S1552-5260(16)00015.
    PubMed     Text format     Abstract available


  182. VERLINDEN VJ, van der Geest JN, de Bruijn RF, Hofman A, et al
    Trajectories of decline in cognition and daily functioning in preclinical dementia.
    Alzheimers Dement. 2016;12:144-53.
    PubMed     Text format     Abstract available


  183. TIWARI MK, Kepp KP
    beta-Amyloid pathogenesis: Chemical properties versus cellular levels.
    Alzheimers Dement. 2016;12:184-94.
    PubMed     Text format     Abstract available


    January 2016
  184. ABNER EL, Nelson PT, Kryscio RJ, Schmitt FA, et al
    Diabetes is associated with cerebrovascular but not Alzheimer neuropathology.
    Alzheimers Dement. 2016 Jan 23. pii: S1552-5260(15)03030.
    PubMed     Text format     Abstract available


  185. PODLESNIY P, Llorens F, Golanska E, Sikorska B, et al
    Mitochondrial DNA differentiates Alzheimer from Creutzfeldt-Jakob disease.
    Alzheimers Dement. 2016 Jan 21. pii: S1552-5260(15)03035.
    PubMed     Text format     Abstract available


  186. KELLER A, Backes C, Haas J, Leidinger P, et al
    Validating Alzheimer's disease micro RNAs using next-generation sequencing.
    Alzheimers Dement. 2016 Jan 21. pii: S1552-5260(15)03036.
    PubMed     Text format     Abstract available


  187. CLARK LR, Racine AM, Koscik RL, Okonkwo OC, et al
    Beta-amyloid and cognitive decline in late middle age: Findings from the Wisconsin Registry for Alzheimer's Prevention study.
    Alzheimers Dement. 2016 Jan 21. pii: S1552-5260(15)03033.
    PubMed     Text format     Abstract available


  188. CASANOVA R, Varma S, Simpson B, Kim M, et al
    Blood metabolite markers of preclinical Alzheimer's disease in two longitudinally followed cohorts of older individuals.
    Alzheimers Dement. 2016 Jan 21. pii: S1552-5260(15)03032.
    PubMed     Text format     Abstract available


  189. DE WILDE MC, Overk CR, Sijben JW, Masliah E, et al
    Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability.
    Alzheimers Dement. 2016 Jan 14. pii: S1552-5260(15)03029.
    PubMed     Text format     Abstract available


  190. HONDIUS DC, van Nierop P, Li KW, Hoozemans JJ, et al
    Profiling the human hippocampal proteome at all pathologic stages of Alzheimer's disease.
    Alzheimers Dement. 2016 Jan 6. pii: S1552-5260(15)02987.
    PubMed     Text format     Abstract available


  191. GAUTHIER S, Albert M, Fox N, Goedert M, et al
    Why has therapy development for dementia failed in the last two decades?
    Alzheimers Dement. 2016;12:60-4.
    PubMed     Text format     Abstract available


  192. PANNEE J, Gobom J, Shaw LM, Korecka M, et al
    Round robin test on quantification of amyloid-beta 1-42 in cerebrospinal fluid by mass spectrometry.
    Alzheimers Dement. 2016;12:55-9.
    PubMed     Text format     Abstract available


  193. GORDON MF, Lenderking WR, Duhig A, Chandler J, et al
    Development of a patient-reported outcome instrument to assess complex activities of daily living and interpersonal functioning in persons with mild cognitive impairment: The qualitative research phase.
    Alzheimers Dement. 2016;12:75-84.
    PubMed     Text format     Abstract available


    December 2015
  194. LEVY NOGUEIRA M, Epelbaum S, Steyaert JM, Dubois B, et al
    Mechanical stress models of Alzheimer's disease pathology.
    Alzheimers Dement. 2015 Dec 21. pii: S1552-5260(15)02952.
    PubMed     Text format     Abstract available


  195. ROLLO JL, Banihashemi N, Vafaee F, Crawford JW, et al
    Unraveling the mechanistic complexity of Alzheimer's disease through systems biology.
    Alzheimers Dement. 2015 Dec 15. pii: S1552-5260(15)02985.
    PubMed     Text format     Abstract available


    November 2015
  196. ZHANG C, Kuo CC, Moghadam SH, Monte L, et al
    Corticotropin-releasing factor receptor-1 antagonism mitigates beta amyloid pathology and cognitive and synaptic deficits in a mouse model of Alzheimer's disease.
    Alzheimers Dement. 2015 Nov 7. pii: S1552-5260(15)02913.
    PubMed     Text format     Abstract available


  197. KHACHATURIAN ZS, Mesulam MM, Khachaturian AS, Mohs RC, et al
    The Special Topics Section of Alzheimer's & Dementia.
    Alzheimers Dement. 2015;11:1261-4.
    PubMed     Text format    


    October 2015
  198. ANDRIEU S, Coley N, Rolland Y, Cantet C, et al
    Assessing Alzheimer's disease patients' quality of life: Discrepancies between patient and caregiver perspectives.
    Alzheimers Dement. 2015 Oct 23. pii: S1552-5260(15)02904.
    PubMed     Text format     Abstract available


  199. EBBERT MT, Boehme KL, Wadsworth ME, Staley LA, et al
    Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.
    Alzheimers Dement. 2015 Oct 5. pii: S1552-5260(15)02866.
    PubMed     Text format     Abstract available


    September 2015
  200. BARRAL S, Cheng R, Reitz C, Vardarajan B, et al
    Linkage analyses in Caribbean Hispanic families identify novel loci associated with familial late-onset Alzheimer's disease.
    Alzheimers Dement. 2015 Sep 30. pii: S1552-5260(15)02650.
    PubMed     Text format     Abstract available


  201. KUNKLE BW, Jaworski J, Barral S, Vardarajan B, et al
    Genome-wide linkage analyses of non-Hispanic white families identify novel loci for familial late-onset Alzheimer's disease.
    Alzheimers Dement. 2015 Sep 10. pii: S1552-5260(15)00224.
    PubMed     Text format     Abstract available


  202. HUBIN E, Vanschoenwinkel B, Broersen K, De Deyn PP, et al
    Could ecosystem management provide a new framework for Alzheimer's disease?
    Alzheimers Dement. 2015 Sep 1. pii: S1552-5260(15)02668.
    PubMed     Text format     Abstract available


  203. LEHMANN S, Gabelle A, Paquet C
    Can we rely only on ratios of cerebrospinal fluid biomarkers for AD biological diagnosis?
    Alzheimers Dement. 2015;11:1125-6.
    PubMed     Text format    


    August 2015
  204. MONTINE TJ, Monsell SE, Beach TG, Bigio EH, et al
    Multisite assessment of NIA-AA guidelines for the neuropathologic evaluation of Alzheimer's disease.
    Alzheimers Dement. 2015 Aug 29. pii: S1552-5260(15)02669.
    PubMed     Text format     Abstract available


  205. TOGA AW, Neu SC, Bhatt P, Crawford KL, et al
    The Global Alzheimer's Association Interactive Network.
    Alzheimers Dement. 2015 Aug 25. pii: S1552-5260(15)02651.
    PubMed     Text format     Abstract available


  206. HYMAN BT, Growdon JH, Albers MW, Buckner RL, et al
    Massachusetts Alzheimer's Disease Research Center: Progress and challenges.
    Alzheimers Dement. 2015 Aug 19. pii: S1552-5260(15)02124.
    PubMed     Text format    


    July 2015
  207. SIEMERS ER, Sundell KL, Carlson C, Case M, et al
    Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients.
    Alzheimers Dement. 2015 Jul 31. pii: S1552-5260(15)02148.
    PubMed     Text format     Abstract available


  208. RAMIREZ J, McNeely AA, Scott CJ, Masellis M, et al
    White matter hyperintensity burden in elderly cohort studies. The Sunnybrook Dementia Study, Alzheimer Disease Neuroimaging Initiative, and Three-City Study.
    Alzheimers Dement. 2015 Jul 21. pii: S1552-5260(15)02123.
    PubMed     Text format     Abstract available


  209. HUNTER CA, Kirson NY, Desai U, Cummings AK, et al
    Medical costs of Alzheimer's disease misdiagnosis among US Medicare beneficiaries.
    Alzheimers Dement. 2015 Jul 20. pii: S1552-5260(15)02126.
    PubMed     Text format     Abstract available


  210. AGADJANYAN MG, Petrovsky N, Ghochikyan A
    A fresh perspective from immunologists and vaccine researchers: Active vaccination strategies to prevent and reverse Alzheimer's disease.
    Alzheimers Dement. 2015 Jul 17. pii: S1552-5260(15)02121.
    PubMed     Text format     Abstract available


  211. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014.
    Alzheimers Dement. 2015;11:865-84.
    PubMed     Text format     Abstract available


  212. JONES-DAVIS DM, Buckholtz N
    The impact of the Alzheimer's Disease Neuroimaging Initiative 2: What role do public-private partnerships have in pushing the boundaries of clinical and basic science research on Alzheimer's disease?
    Alzheimers Dement. 2015;11:860-4.
    PubMed     Text format     Abstract available


  213. HENDRIX JA, Finger B, Weiner MW, Frisoni GB, et al
    The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update.
    Alzheimers Dement. 2015;11:850-9.
    PubMed     Text format     Abstract available


  214. LIU E, Luthman J, Cedarbaum JM, Schmidt ME, et al
    Perspective: The Alzheimer's Disease Neuroimaging Initiative and the role and contributions of the Private Partner Scientific Board (PPSB).
    Alzheimers Dement. 2015;11:840-9.
    PubMed     Text format     Abstract available


  215. TOGA AW, Crawford KL
    The Alzheimer's Disease Neuroimaging Initiative informatics core: A decade in review.
    Alzheimers Dement. 2015;11:832-9.
    PubMed     Text format     Abstract available


  216. BECKETT LA, Donohue MC, Wang C, Aisen P, et al
    The Alzheimer's Disease Neuroimaging Initiative phase 2: Increasing the length, breadth, and depth of our understanding.
    Alzheimers Dement. 2015;11:823-31.
    PubMed     Text format     Abstract available


  217. FRANKLIN EE, Perrin RJ, Vincent B, Baxter M, et al
    Brain collection, standardized neuropathologic assessment, and comorbidity in Alzheimer's Disease Neuroimaging Initiative 2 participants.
    Alzheimers Dement. 2015;11:815-22.
    PubMed     Text format     Abstract available


  218. KANG JH, Korecka M, Figurski MJ, Toledo JB, et al
    The Alzheimer's Disease Neuroimaging Initiative 2 Biomarker Core: A review of progress and plans.
    Alzheimers Dement. 2015;11:772-91.
    PubMed     Text format     Abstract available


  219. JAGUST WJ, Landau SM, Koeppe RA, Reiman EM, et al
    The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015.
    Alzheimers Dement. 2015;11:757-71.
    PubMed     Text format     Abstract available


  220. JACK CR JR, Barnes J, Bernstein MA, Borowski BJ, et al
    Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2.
    Alzheimers Dement. 2015;11:740-56.
    PubMed     Text format     Abstract available


  221. AISEN PS, Petersen RC, Donohue M, Weiner MW, et al
    Alzheimer's Disease Neuroimaging Initiative 2 Clinical Core: Progress and plans.
    Alzheimers Dement. 2015;11:734-9.
    PubMed     Text format     Abstract available


  222. WEINER MW, Veitch DP
    Introduction to special issue: Overview of Alzheimer's Disease Neuroimaging Initiative.
    Alzheimers Dement. 2015;11:730-3.
    PubMed     Text format     Abstract available


  223. THIES WH
    Alzheimer's Disease Neuroimaging Initiative: A decade of progress in Alzheimer's disease.
    Alzheimers Dement. 2015;11:727-9.
    PubMed     Text format    


    June 2015
  224. THAL DR, Beach TG, Zanette M, Heurling K, et al
    [F]flutemetamol amyloid positron emission tomography in preclinical and symptomatic Alzheimer's disease: Specific detection of advanced phases of amyloid-beta pathology.
    Alzheimers Dement. 2015 Jun 30. pii: S1552-5260(15)00216.
    PubMed     Text format     Abstract available


  225. LIU H, Qiu H, Yang J, Ni J, et al
    Chronic hypoxia facilitates Alzheimer's disease through demethylation of gamma-secretase by downregulating DNA methyltransferase 3b.
    Alzheimers Dement. 2015 Jun 26. pii: S1552-5260(15)00217.
    PubMed     Text format     Abstract available


  226. HOHMAN TJ, Cooke-Bailey JN, Reitz C, Jun G, et al
    Global and local ancestry in African-Americans: Implications for Alzheimer's disease risk.
    Alzheimers Dement. 2015 Jun 16. pii: S1552-5260(15)00190.
    PubMed     Text format     Abstract available


  227. DE VOS A, Jacobs D, Struyfs H, Fransen E, et al
    C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease.
    Alzheimers Dement. 2015 Jun 16. pii: S1552-5260(15)00181.
    PubMed     Text format     Abstract available


  228. LEVY NOGUEIRA M, Lafitte O, Steyaert JM, Bakardjian H, et al
    Mechanical stress related to brain atrophy in Alzheimer's disease.
    Alzheimers Dement. 2015 Jun 15. pii: S1552-5260(15)00196.
    PubMed     Text format     Abstract available


  229. SLEEGERS K, Bettens K, De Roeck A, Cauwenberghe CV, et al
    A 22-single nucleotide polymorphism Alzheimer risk score correlates with family history, onset age, and cerebrospinal fluid Abeta.
    Alzheimers Dement. 2015 Jun 15. pii: S1552-5260(15)00191.
    PubMed     Text format     Abstract available


  230. MUKHERJEE S, Walter S, Kauwe JS, Saykin AJ, et al
    Genetically predicted body mass index and Alzheimer's disease-related phenotypes in three large samples: Mendelian randomization analyses.
    Alzheimers Dement. 2015 Jun 12. pii: S1552-5260(15)00184.
    PubMed     Text format     Abstract available


  231. ROSEN C, Farahmand B, Skillback T, Nagga K, et al
    Benchmarking biomarker-based criteria for Alzheimer's disease-Data from the Swedish Dementia Registry, SveDem.
    Alzheimers Dement. 2015 Jun 12. pii: S1552-5260(15)00185.
    PubMed     Text format     Abstract available


  232. NORDESTGAARD LT, Tybjaerg-Hansen A, Nordestgaard BG, Frikke-Schmidt R, et al
    Loss-of-function mutation in ABCA1 and risk of Alzheimer and cerebrovascular disease.
    Alzheimers Dement. 2015 Jun 12. pii: S1552-5260(15)00180.
    PubMed     Text format     Abstract available


  233. LUTZ MW, Saul R, Linnertz C, Glenn OC, et al
    A CT-rich haplotype in intron 4 of SNCA confers risk for Lewy body pathology in Alzheimer's disease and affects SNCA expression.
    Alzheimers Dement. 2015 Jun 12. pii: S1552-5260(15)00179.
    PubMed     Text format     Abstract available


  234. HANDELS RL, Joore MA, Tran-Duy A, Wimo A, et al
    Early cost-utility analysis of general and cerebrospinal fluid-specific Alzheimer's disease biomarkers for hypothetical disease-modifying treatment decision in mild cognitive impairment.
    Alzheimers Dement. 2015 Jun 9. pii: S1552-5260(15)00176.
    PubMed     Text format     Abstract available


  235. WEINER MW, Veitch DP, Aisen PS, Beckett LA, et al
    2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.
    Alzheimers Dement. 2015;11:e1-e120.
    PubMed     Text format     Abstract available


    May 2015
  236. RISACHER SL, Kim S, Nho K, Foroud T, et al
    APOE effect on Alzheimer's biomarkers in older adults with significant memory concern.
    Alzheimers Dement. 2015 May 7. pii: S1552-5260(15)00124.
    PubMed     Text format     Abstract available


  237. PASQUINI L, Scherr M, Tahmasian M, Meng C, et al
    Link between hippocampus' raised local and eased global intrinsic connectivity in AD.
    Alzheimers Dement. 2015;11:475-84.
    PubMed     Text format     Abstract available


    April 2015
  238. HUANG Y, Ito K, Billing CB Jr, Anziano RJ, et al
    Development of a straightforward and sensitive scale for MCI and early AD clinical trials.
    Alzheimers Dement. 2015;11:404-14.
    PubMed     Text format     Abstract available


    March 2015

  239. 2015 Alzheimer's disease facts and figures.
    Alzheimers Dement. 2015;11:332-84.
    PubMed     Text format     Abstract available


    February 2015
  240. FRISONI GB, Jack CR
    HarP: the EADC-ADNI Harmonized Protocol for manual hippocampal segmentation. A standard of reference from a global working group.
    Alzheimers Dement. 2015;11:107-10.
    PubMed     Text format    


  241. APOSTOLOVA LG, Zarow C, Biado K, Hurtz S, et al
    Relationship between hippocampal atrophy and neuropathology markers: a 7T MRI validation study of the EADC-ADNI Harmonized Hippocampal Segmentation Protocol.
    Alzheimers Dement. 2015;11:139-50.
    PubMed     Text format     Abstract available


  242. DUCHESNE S, Valdivia F, Robitaille N, Mouiha A, et al
    Manual segmentation qualification platform for the EADC-ADNI harmonized protocol for hippocampal segmentation project.
    Alzheimers Dement. 2015;11:161-74.
    PubMed     Text format     Abstract available


  243. BOCCARDI M, Bocchetta M, Morency FC, Collins DL, et al
    Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol.
    Alzheimers Dement. 2015;11:175-83.
    PubMed     Text format     Abstract available


  244. FRISONI GB, Jack CR Jr, Bocchetta M, Bauer C, et al
    The EADC-ADNI Harmonized Protocol for manual hippocampal segmentation on magnetic resonance: evidence of validity.
    Alzheimers Dement. 2015;11:111-25.
    PubMed     Text format     Abstract available


  245. BOCCHETTA M, Boccardi M, Ganzola R, Apostolova LG, et al
    Harmonized benchmark labels of the hippocampus on magnetic resonance: the EADC-ADNI project.
    Alzheimers Dement. 2015;11:151-60.
    PubMed     Text format     Abstract available


  246. BOCCHETTA M, Galluzzi S, Kehoe PG, Aguera E, et al
    The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey.
    Alzheimers Dement. 2015;11:195-206.
    PubMed     Text format     Abstract available


  247. BOCCARDI M, Bocchetta M, Apostolova LG, Barnes J, et al
    Delphi definition of the EADC-ADNI Harmonized Protocol for hippocampal segmentation on magnetic resonance.
    Alzheimers Dement. 2015;11:126-38.
    PubMed     Text format     Abstract available


  248. DAIELLO LA, Gongvatana A, Dunsiger S, Cohen RA, et al
    Association of fish oil supplement use with preservation of brain volume and cognitive function.
    Alzheimers Dement. 2015;11:226-35.
    PubMed     Text format     Abstract available


  249. BOCCARDI M, Bocchetta M, Ganzola R, Robitaille N, et al
    Operationalizing protocol differences for EADC-ADNI manual hippocampal segmentation.
    Alzheimers Dement. 2015;11:184-94.
    PubMed     Text format     Abstract available


    January 2015
  250. KLUNK WE, Koeppe RA, Price JC, Benzinger TL, et al
    The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET.
    Alzheimers Dement. 2015;11:1-15.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: